Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Sarver

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Journal of Virology|November 1, 1984
Localization and analysis of bovine papillomavirus type 1 transforming functionsN Sarver, M S Rabson, Y C Yang, et al.
Journal of the National Cancer Institute|October 18, 1989
Oligodeoxynucleotides as anti-sense inhibitors of gene expression: therapeutic implicationsM Rothenberg, G Johnson, C Laughlin, et al.
DNA (Mary Ann Liebert, Inc.)|December 1, 1987
Stable expression of recombinant factor VIII molecules using a bovine papillomavirus vectorN Sarver, G A Ricca, J Link, et al.
AIDS Research and Human Retroviruses|August 1, 1994
Cellular distribution of HIV type 1 Nef protein: identification of domains in Nef required for association with membrane and detergent-insoluble cellular matrixJ Kaminchik, R Margalit, S Yaish, et al.
The Journal of Biological Chemistry|November 15, 1991
EGF induces increased ligand binding affinity and dimerization of soluble epidermal growth factor (EGF) receptor extracellular domainD R Hurwitz, S L Emanuel, M H Nathan, et al.
Science (New York, N.Y.)|March 9, 1990
Ribozymes as potential anti-HIV-1 therapeutic agentsN Sarver, E M Cantin, P S Chang, et al.
Journal of Virology|July 1, 1990
Expression and biochemical characterization of human immunodeficiency virus type 1 nef gene productJ Kaminchik, N Bashan, D Pinchasi, et al.
Annals of the New York Academy of Sciences|January 1, 1990
Ribozymes as therapies for AIDSJ J Rossi, E M Cantin, J A Zaia, et al.
Human Gene Therapy|February 18, 1999
Bone marrow stromal cell-mediated gene therapy for hemophilia A: in vitro expression of human factor VIII with high biological activity requires the inclusion of the proteolytic site at amino acid 1648G G Chiang, H L Rubin, V Cherington, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Journal of Virology|November 1, 1984
Localization and analysis of bovine papillomavirus type 1 transforming functionsN Sarver, M S Rabson, Y C Yang, et al.
Journal of the National Cancer Institute|October 18, 1989
Oligodeoxynucleotides as anti-sense inhibitors of gene expression: therapeutic implicationsM Rothenberg, G Johnson, C Laughlin, et al.
DNA (Mary Ann Liebert, Inc.)|December 1, 1987
Stable expression of recombinant factor VIII molecules using a bovine papillomavirus vectorN Sarver, G A Ricca, J Link, et al.
AIDS Research and Human Retroviruses|August 1, 1994
Cellular distribution of HIV type 1 Nef protein: identification of domains in Nef required for association with membrane and detergent-insoluble cellular matrixJ Kaminchik, R Margalit, S Yaish, et al.
The Journal of Biological Chemistry|November 15, 1991
EGF induces increased ligand binding affinity and dimerization of soluble epidermal growth factor (EGF) receptor extracellular domainD R Hurwitz, S L Emanuel, M H Nathan, et al.
Science (New York, N.Y.)|March 9, 1990
Ribozymes as potential anti-HIV-1 therapeutic agentsN Sarver, E M Cantin, P S Chang, et al.
Journal of Virology|July 1, 1990
Expression and biochemical characterization of human immunodeficiency virus type 1 nef gene productJ Kaminchik, N Bashan, D Pinchasi, et al.
Annals of the New York Academy of Sciences|January 1, 1990
Ribozymes as therapies for AIDSJ J Rossi, E M Cantin, J A Zaia, et al.
Human Gene Therapy|February 18, 1999
Bone marrow stromal cell-mediated gene therapy for hemophilia A: in vitro expression of human factor VIII with high biological activity requires the inclusion of the proteolytic site at amino acid 1648G G Chiang, H L Rubin, V Cherington, et al.
Pageof 4